Search
Ketamine Treatment Options in New York
A collection of 109 research studies where Ketamine is the interventional treatment. These studies are located in the New York, United States. Ketamine is used for conditions such as Pain, Major Depressive Disorder and Depression.
73 - 84 of 109
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Chronic Cough Research Study
Recruiting
Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!
Conditions:
Chronic Cough
Refractory or Unexplained Chronic Cough
Cough
Asthma
Sinusitis
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery.
Completed
The purpose of this study is to determine if there is a difference in patient outcomes with general anesthesia versus spinal anesthesia when given in addition to popliteal and adductor canal nerve blocks for foot and ankle surgery. Popliteal and adductor canal nerve blocks are injections of local anesthetic agents near nerves in the back and front of the knee going to the foot and ankle that provide numbness during and after surgery. These peripheral nerve blocks offer good pain control and redu... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
11/07/2019
Locations: Hospital for Special Surgery, New York, New York, New York
Conditions: Nerve Block, General Anesthesia, Spinal Anesthesia, Pain, Postoperative Nausea and Vomiting
Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Completed
This study is examining the safety and effectiveness of two medications, ketamine and riluzole, in treating patients with treatment resistant major depressive disorder. This study will also examine the effectiveness of an FDA approved drug called lamotrigine in decreasing the potential side effects associated with ketamine.
Gender:
ALL
Ages:
Between 21 years and 70 years
Trial Updated:
07/16/2019
Locations: Mount Sinai School of Medicine, New York, New York
Conditions: Major Depression
Geriatric Ketamine for Pain Management Study
Completed
This research project is geared towards geriatric analgesia in the Emergency Department (ED) with a goal of reducing the administration of opioid pain medications to elderly patients, thereby avoiding the commonly occurring, severe side effects associated with such medications, including hypotension, respiratory depression, altered mental status, delirium, as well as nausea/vomiting and constipation.
The primary outcome of the study will be difference in pain score from baseline to 30 minutes p... Read More
Gender:
ALL
Ages:
Between 65 years and 120 years
Trial Updated:
05/30/2019
Locations: Maimonides Medical Center, Brooklyn, New York
Conditions: Pain
The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
Terminated
This project will evaluate the effect of a single sub-anesthetic dose of ketamine on the time to first cocaine use and abstinence rates in 60 treatment-seeking cocaine-dependent individuals receiving mindfulness-based relapse prevention (MBRP) therapy, using a 5 week combined laboratory-inpatient and outpatient double-blind, randomized, controlled trial.
Gender:
ALL
Ages:
Between 21 years and 60 years
Trial Updated:
04/16/2019
Locations: New York State Psychiatric Institute, New York, New York
Conditions: Cocaine Dependence
Glutamatergic Modulation of Cocaine-related Deficits
Completed
Cocaine dependence involves problematic neuroadaptations, such as heightened reactivity to cocaine cues, that may be responsive to pharmacological modulation of glutamatergic circuits. Despite promising preclinical findings with n-methyl-d-aspartate receptor (NMDAr) modulators, studies with human subjects have been unsuccessful to date. The purpose of this investigation is to examine the effects of the NMDAr antagonist ketamine, recently found to have potent therapeutic effects in humans, on cue... Read More
Gender:
ALL
Ages:
Between 21 years and 52 years
Trial Updated:
04/16/2019
Locations: NYSPI, New York, New York
Conditions: Cocaine Dependence
Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
Completed
Investigators will conduct a trial to evaluate the use of Ketamine as an alternate treatment for people with Major Depressive Disorder. This study plans to explore the potential that Ketamine's rapid antidepressant action holds for improving outcomes in patients presenting to the Emergency Department with severe depression. Since this is a controlled trial we will use an IV of Ketamine or and equivalent volume of Diphenhydramine. Subjects will be randomly assigned to receive Ketamine or Benadryl... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/16/2018
Locations: Bellevue Hospital Center, New York, New York +1 locations
Conditions: Depression
Biomarker Assessment of Glutamatergic Target Engagement
Completed
The purpose of this study is to assess the relative feasibility of 2 potential functional measures of target engagement (Glx MRS, BOLD fMRI) to systematically assess mGluR 2/3 in drug development for psychotic spectrum disorders.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
08/15/2018
Locations: New York State Psychiatric Institute, New York, New York
Conditions: Healthy Controls
Ketamine Plus Lithium in Treatment-Resistant Depression
Completed
The purpose of this study is to test the antidepressant effect of ketamine when given repeatedly over a period of 1 week, as well as the use of Lithium as a relapse-prevention strategy for patients with treatment-resistant depression (TRD) who respond to an initial series of ketamine infusions. Ketamine is a Food and Drug Administration approved anesthetic (a drug used to produce loss of consciousness before and during surgery). Ketamine is not approved for the treatment of major depressive diso... Read More
Gender:
ALL
Ages:
Between 21 years and 65 years
Trial Updated:
07/05/2018
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Depression
Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
Unknown
The hypothesis of the study is that sub-dissociative dose ketamine will prove to be superior to or as standard therapy, ketorolac, in the treatment of acute tension type headache (TTH) as measured by the 10 point Numerical Rating Scale (NRS. The aim of the study is to compare the safety \& efficacy of intravenous sub-dissociative dose ketamine versus ketorolac for acute treatment of migraines in the Emergency Department (ED) The primary endpoints are: Patient perception of pain as described by t... Read More
Gender:
MALE
Ages:
Between 18 years and 65 years
Trial Updated:
07/05/2018
Locations: The Brooklyn Hospital Center, Brooklyn, New York
Conditions: Migraine
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
Completed
This study is looking at the efficacy, durability, safety, and tolerability of multiple single doses of Ketamine vs. active placebo for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
05/24/2018
Locations: Mount Sinai School of Medicine, New York, New York
Conditions: Treatment Resistant Depression
A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion
Completed
The aim of the proposed study is to examine the effectiveness of low dose postoperative ketamine infusion as an analgesic adjuvant to morphine pca in opioid tolerant and opioid naïve patients after major spine surgery. Primary endpoints of the study are to determine the effectiveness of postoperative ketamine infusion in for the reduction of postoperative pain and opioid requirements.
Gender:
ALL
Ages:
16 years and above
Trial Updated:
05/15/2018
Locations: New York University School of Medicine, New York, New York
Conditions: Spinal Fusion
Pediatric Ketamine Study for Pain Management
Terminated
Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.
Gender:
ALL
Ages:
Between 3 years and 17 years
Trial Updated:
05/07/2018
Locations: Maimonides Medical Center, Brooklyn, New York
Conditions: Pain
73 - 84 of 109